When individuals agree to serve on the board of directors of a US corporation, they assume a set of legal obligations that run to the corporation and, derivatively, to its shareholders. These obligations are collectively described as fiduciary duties, and they represent one of the most extensively litigated areas of corporate governance law. For public companies, the consequences of a breach can include shareholder derivative suits, class action litigation, SEC enforcement, and lasting reputational harm. For private companies, including closely held corporations, family businesses, and venture-backed startups, fiduciary duty disputes between directors and shareholders are an equally significant source of litigation and personal liability risk. Understanding what these duties require — and how courts assess whether they have been satisfied — is essential for every director, officer, and business owner in the United States.

The law of fiduciary duties in the United States is developed primarily at the state level, and Delaware law is by far the most influential. Because more than two-thirds of Fortune 500 companies and a majority of all publicly traded US corporations are incorporated in Delaware, the Delaware Court of Chancery and the Delaware Supreme Court have produced the most sophisticated and widely followed body of corporate fiduciary duty law in the country. Other states frequently look to Delaware decisions for guidance, though important variations exist. This discussion focuses primarily on Delaware law while noting where other jurisdictions diverge in material ways.

The Duty of Care

The duty of care requires directors to act on an informed basis, in good faith, and in the honest belief that their actions are in the best interests of the corporation. At its core, the duty of care is about process: it demands that directors make decisions after acquiring the information reasonably necessary to make a sound judgment. A director who makes a business decision without reviewing relevant financial information, without consulting appropriate advisors, or without giving the matter adequate deliberation may have failed the duty of care, even if the ultimate decision was substantively reasonable.

Delaware courts apply a gross negligence standard to duty of care claims arising from business decisions. Ordinary negligence — falling short of the care a reasonable person would exercise — is not sufficient to establish a breach. A director must have been grossly negligent, meaning the failure must have been so extreme as to constitute reckless disregard for the interests of the corporation. This is a demanding standard, and it reflects a judicial policy judgment that courts should not routinely second-guess business decisions simply because they turned out badly. The landmark case of Smith v. Van Gorkom, decided by the Delaware Supreme Court in 1985, remains the most prominent example of a court finding gross negligence. In that case, the Trans Union board approved a merger in a brief meeting, without obtaining a fairness opinion or reviewing the merger agreement, based primarily on the recommendation of the company’s CEO. The court found this process so deficient as to constitute gross negligence, holding the directors personally liable for damages. Van Gorkom sent shockwaves through the corporate world and directly prompted the Delaware legislature to enact Section 102(b)(7) of the Delaware General Corporation Law.

Section 102(b)(7) allows Delaware corporations to include in their certificates of incorporation a provision eliminating or limiting the personal monetary liability of directors for breaches of the duty of care. Most Delaware corporations — public and private alike — include such an exculpation provision in their charters. The practical effect is that duty of care claims, standing alone, rarely result in personal monetary liability for directors of companies with such provisions. The exculpation does not apply to breaches of the duty of loyalty, bad faith conduct, intentional misconduct, knowing violations of law, or transactions from which the director derived an improper personal benefit. A 2022 amendment to the DGCL extended exculpation to certain officers as well as directors — a significant development that reflects evolving views on the appropriate scope of personal liability for senior corporate fiduciaries.

The duty of care has both a transactional dimension and an oversight dimension. The transactional duty of care concerns the process directors use when making specific decisions — approving a merger, authorizing a capital raise, adopting a significant business strategy. The oversight dimension, sometimes called the duty of oversight or the Caremark duty (discussed in a separate article), concerns the ongoing obligation of directors to ensure that adequate systems exist to monitor corporate compliance and detect wrongdoing. Both dimensions require a reasonable process, though the standards and consequences differ.

Practical steps directors take to satisfy the duty of care include: obtaining and reviewing relevant financial, legal, and strategic information before voting on significant matters; ensuring that the board has adequate time to deliberate and ask questions; retaining qualified independent advisors (investment bankers, lawyers, financial experts) for major transactions; relying in good faith on management presentations and expert reports (reliance protection is expressly provided under Delaware law where the director is entitled to rely on the information presented); and maintaining accurate records of the deliberative process through board minutes. Well-documented minutes that reflect the information reviewed, the questions asked, and the basis for the board’s decision are among the most important protections a board can have in any subsequent litigation.

The Duty of Loyalty

The duty of loyalty requires directors to act in the best interests of the corporation and its shareholders, not in their own interests or the interests of third parties. Where the duty of care is primarily about process, the duty of loyalty is primarily about conflict: it prohibits directors from placing their personal interests — financial or otherwise — ahead of the corporation’s. The duty of loyalty encompasses several related doctrines: the prohibition on self-dealing transactions, the corporate opportunity doctrine, the prohibition on usurping corporate opportunities, and the obligations that arise in the context of change-of-control transactions.

Self-dealing occurs when a director stands on both sides of a transaction with the corporation — for example, when the corporation purchases assets from, sells assets to, or enters into a contract with an entity in which a director has a material financial interest. Self-dealing transactions are not automatically void, but they are subject to heightened scrutiny. Under Delaware law, a conflicted transaction can be validated through one of three safe harbors: (1) the transaction is approved by a majority of disinterested, independent directors after full disclosure of the conflict; (2) the transaction is approved by a majority of disinterested shareholders after full disclosure; or (3) the transaction is entirely fair to the corporation. If none of these conditions is met, the transaction may be voided and the conflicted director may be required to disgorge any profits. The burden of proving entire fairness falls on the defendants — the directors who approved the transaction — unless the conflict was properly disclosed and the transaction was approved through an appropriate procedural mechanism.

The corporate opportunity doctrine is an extension of the duty of loyalty that prohibits directors and officers from appropriating for personal benefit business opportunities that belong to the corporation. A business opportunity belongs to the corporation if it is in the company’s line of business, if the company has an expectancy or interest in it, or if taking the opportunity would create a conflict of interest. A director who learns of a profitable acquisition target, investment opportunity, or business deal in the course of serving on the board — and who then pursues that opportunity personally without first offering it to the corporation — may have usurped a corporate opportunity. Delaware law permits corporations to renounce in advance their interest in specified categories of business opportunities, which is particularly important for boards that include representatives of venture capital or private equity firms who sit on the boards of multiple portfolio companies.

In the context of mergers and acquisitions, the duty of loyalty takes on particular importance. Where directors have a financial interest in a proposed transaction — for example, where they will receive accelerated vesting of equity awards, enhanced severance, or continued employment in the post-merger entity — courts may apply enhanced scrutiny or the entire fairness standard rather than the more deferential business judgment rule. The so-called MFW framework (after the Delaware Supreme Court’s decision in Kahn v. M&F Worldwide Corp.) provides a path for controlling shareholders proposing a going-private transaction to obtain business judgment review rather than entire fairness review, but only if the transaction is conditioned from the outset on the approval of both an independent special committee and a majority of minority shareholders. This dual protection mechanism has become a best-practice template for controlling shareholder transactions.

Bad faith is sometimes treated as a component of the duty of loyalty rather than a standalone duty. Under Delaware law, conduct constitutes bad faith when a director intentionally acts in a manner contrary to the best interests of the corporation — for example, by consciously disregarding a known duty to act, or by acting with an intent to harm the company. Unlike the duty of care, which may be exculpated, bad faith conduct is not subject to exculpation and can give rise to personal monetary liability. Directors who are not acting against the company’s interests but who are deeply inattentive, uninformed, or disengaged may also face Caremark oversight liability, which is discussed separately.

The Business Judgment Rule

The business judgment rule is the default standard of judicial review for corporate board decisions. It is both a standard of review and a presumption: courts presume that in making a business decision, the directors acted on an informed basis, in good faith, and in the honest belief that the action was in the best interests of the company. A plaintiff challenging a board decision under the business judgment rule bears the burden of rebutting this presumption. If the plaintiff cannot rebut the presumption, the court will not disturb the board’s decision, even if the court would have made a different choice.

The policy rationale for the business judgment rule is deeply rooted in the separation of powers between the judiciary and the boardroom. Courts recognize that directors are better positioned than judges to evaluate complex business decisions. Business decisions involve risk, uncertainty, and judgment calls for which there is often no objectively correct answer. If courts regularly second-guessed board decisions on the merits, the result would be excessive judicial intervention in corporate management and excessive risk-aversion by directors who feared personal liability for decisions that turned out badly. The business judgment rule prevents this by insulating directors from liability for good-faith business judgments, even mistaken ones, provided the process was reasonable.

The rule has four elements that directors must satisfy: the directors must have been disinterested and independent (no material financial conflict); they must have been adequately informed (duty of care); they must have acted in good faith; and they must not have acted in a wasteful manner (a transaction is waste only if no reasonable person could consider it fair to the corporation). Where all four elements are present, the court will uphold the board’s decision regardless of the outcome. Only where the presumption is successfully rebutted does the standard of review shift from business judgment to entire fairness or enhanced scrutiny.

Two circumstances trigger enhanced scrutiny rather than the business judgment rule. The first is the Unocal context: where a board adopts defensive measures in response to a hostile takeover attempt, Delaware courts apply the two-part Unocal test. The board must first show that it had reasonable grounds to believe a threat to corporate policy and effectiveness existed; and second, that the defensive response was reasonable in relation to the threat posed. Preclusive or coercive defensive measures are impermissible even if the threat was genuine. The second enhanced scrutiny context is the Revlon context: where a board has decided to sell the company or break it up, triggering a change of corporate control, the board must take reasonable steps to obtain the best available price for shareholders. The Revlon doctrine applies only when the sale will result in a change of control; it does not apply in stock-for-stock mergers where both companies’ shareholders retain a significant equity stake in the resulting entity.

Where a plaintiff successfully rebuts the business judgment presumption — by showing that a director had a material financial interest in the decision, that the board was not adequately informed, or that the directors acted in bad faith — the standard of review shifts to entire fairness. Under the entire fairness standard, the burden shifts to the defendants to prove that the challenged transaction was entirely fair to the corporation. Entire fairness has two components: fair dealing and fair price. Fair dealing concerns the process — how the transaction was structured, initiated, disclosed, negotiated, and approved. Fair price concerns the economic terms — whether the consideration was fair from a financial point of view. Both components must be satisfied; a fair price alone does not redeem an unfair process, and vice versa.

Indemnification and D&O Insurance

Given the liability exposure that directors face, indemnification and directors and officers (D&O) insurance are essential tools for attracting and retaining qualified board members. Delaware law permits — and in some circumstances requires — corporations to indemnify directors and officers who are made party to proceedings by reason of their service as a director or officer, provided they acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the corporation. Mandatory indemnification applies where the director has been wholly successful on the merits or otherwise in defense of a proceeding. Permissive indemnification applies in other circumstances, subject to a determination that the standard of conduct was met.

D&O insurance provides a critical backstop, particularly for situations where indemnification is unavailable — for example, where the corporation is insolvent, where indemnification is legally prohibited, or where a settlement involves a derivative action in which the corporation itself is the nominal plaintiff. D&O policies typically have three coverage parts: Side A coverage for directors and officers when the company cannot indemnify them; Side B coverage for the company’s indemnification payments on behalf of directors and officers; and Side C coverage for securities claims against the company itself. The adequacy of D&O coverage — including the limits, the retention, and the scope of the policy — is itself a matter of board governance that deserves careful attention from the compensation or governance committee.

Practical Guidance for Directors

Directors who wish to protect themselves from liability and discharge their fiduciary duties effectively should follow several principles consistently. First, attend and engage. Directors who miss meetings, skip committee sessions, or participate only perfunctorily are at far greater legal risk than those who are demonstrably engaged. Courts and plaintiffs’ lawyers look at attendance records and participation levels. Second, read the materials. Board packages typically contain substantial information; directors who vote on matters they have not reviewed cannot claim the protection of the business judgment rule’s informed decision requirement. Third, ask questions. A director who has reservations about a proposed transaction or strategy should raise them — and the board should take time to address material concerns before proceeding to a vote. Fourth, dissent when appropriate. A director who votes against a proposal, or who abstains and notes the abstention in the minutes, is in a far stronger legal position than one who goes along without objection. Fifth, rely on advisors. Delaware law specifically permits directors to rely in good faith on the advice of legal counsel, financial advisors, accountants, and other experts, provided the reliance is reasonable. Retaining qualified advisors and genuinely consulting them — rather than simply rubber-stamping their conclusions — is both good practice and good legal protection. Sixth, disclose conflicts. Any director who has a material personal interest in a transaction before the board should disclose that interest fully and recuse from the vote. Proper recusal transforms a potentially conflicted vote into a protected one.

For private company directors, particularly those who sit on boards of closely held or family-owned corporations, fiduciary duty litigation is often the result of disputes between majority and minority shareholders. Delaware courts have held that controlling shareholders in closely held corporations owe fiduciary duties to minority shareholders directly, not merely through the corporate entity. This means that a controlling shareholder who causes the corporation to favor the controller’s interests at the expense of minority shareholders may face a direct fiduciary duty claim, in addition to any derivative claim the corporation might have. Private company directors should be particularly attentive to the fairness of related-party transactions, equity dilution decisions, and dividend policies, all of which are common flashpoints for fiduciary duty litigation in the closely held company context.

The fiduciary duties of care and loyalty, and the business judgment rule’s role as the default standard of review, form the foundational architecture of US corporate governance. They define what it means to be a director, what directors owe to those who trust them with the stewardship of the corporation, and what standards courts will apply when that trust is alleged to have been violated. Directors who internalize these principles — and who build governance processes around them — are best positioned to lead effectively and to defend against the legal challenges that are an increasingly common feature of corporate life in America.

See Also